Αποτελέσματα Αναζήτησης
30 Νοε 2021 · The 5-year cancer-specific survival and overall survival (OS) rates range from 50% to 82% and from 36% to 74%, respectively, with salvage RC rates of ∼20% for studies with a follow-up >5 years. 45, 46 The pooled rate of non-response to trimodal therapy and local recurrence after trimodal therapy, the two primary reasons for salvage RC, is ...
15 Ιαν 2019 · Undergoing radiotherapy near the pelvis could increase your risk of bladder cancer. Treatment . Treatment for bladder cancer will depend on the type and extent of the cancer. In early and non-muscle invasive bladder cancer, the cancer can be removed without needing to remove the bladder.
The side effects of treatment have translated to patient refusal of BCG therapy. Dysuria has been reported in 60% of patients in clinical trials. 56 However, the side effects are treatable in almost all cases, 57 and no increase in toxicity has been reported with cumulative doses.
16 Σεπ 2021 · We checked in with diabetes specialist Sonali Thosani, M.D., to learn about this potential side effect of cancer treatment, and what — if anything — can be done to reverse it. How common is it for cancer patients to develop secondary diabetes as a result of their treatment or its side effects?
12 Φεβ 2024 · The study concluded that in patients with BCG unresponsive bladder carcinoma in situ and papillary NMIBC treated with BCG and the novel agent NAI, complete response was achieved with a persistence of effect, cystectomy avoidance, and 100% bladder cancer specific survival at 24 months.
12 Νοε 2022 · We review the management of non-muscle-invasive bladder cancer (NMIBC), muscle-invasive bladder cancer (MIBC), and metastatic urothelial cancer from a radio-oncological, urological, and oncological point of view, highlighting the European and North American perspectives on best practice.
(3 or 4 cycles) in patients with muscle-invasive bladder cancer. 2,8,9 • Meta-analysis suggests a survival benefit to adjuvant therapy for pathologic T3, T4, or N+ disease at cystectomy. 9
